Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A Charlton

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Anti-Cancer Drugs|September 23, 2000
Ex vivo activity of XR5000 against solid tumorsM H Neale, P A Charlton, I A Cree
Life Sciences|January 1, 1989
Atrial natriuretic factor in the Langendorff perfused coronary vasculature of the rabbit isolated heartS S Klair, J B Louttit, P A Charlton
European Journal of Pharmacology|January 17, 1991
Acute and chronic effects of renin inhibitor GR70982 in the conscious marmosetC J Gardner, D J Twissell, P A Charlton, et al.
British Journal of Cancer|February 9, 2005
Antitumour activity of XR5944 in vitro and in vivo in combination with 5-fluorouracil and irinotecan in colon cancer cell linesS M Harris, P Mistry, C Freathy, et al.
Cancer Letters|January 24, 2007
Structural basis for potent inhibition of the Aurora kinases and a T315I multi-drug resistant mutant form of Abl kinase by VX-680G M T Cheetham, P A Charlton, J M C Golec, et al.
The International Journal of Biochemistry|February 1, 1992
Inhibition of aspartic proteinases by synthetic peptides derived from the propart region of human proreninA D Richards, J Kay, B M Dunn, et al.
The Biochemical Journal|April 1, 1987
The rapid purification and partial characterization of human serum angiotensinogenC J Campbell, P A Charlton, C J Grinham, et al.
The Journal of Pediatrics|August 10, 2000
Nutritional rickets in African American breast-fed infantsS R Kreiter, R P Schwartz, H N Kirkman, et al.
Biochemistry|March 31, 1981
Hydrogen-1 nuclear magnetic resonance study of the complexes of two diastereoisomers of folinic acid with dihydrofolate reductaseJ Feeney, B Birdsall, J P Albrand, et al.
Thrombosis and Haemostasis|May 1, 1996
Evaluation of a low molecular weight modulator of human plasminogen activator inhibitor-1 activityP A Charlton, R W Faint, F Bent, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Anti-Cancer Drugs|September 23, 2000
Ex vivo activity of XR5000 against solid tumorsM H Neale, P A Charlton, I A Cree
Life Sciences|January 1, 1989
Atrial natriuretic factor in the Langendorff perfused coronary vasculature of the rabbit isolated heartS S Klair, J B Louttit, P A Charlton
European Journal of Pharmacology|January 17, 1991
Acute and chronic effects of renin inhibitor GR70982 in the conscious marmosetC J Gardner, D J Twissell, P A Charlton, et al.
British Journal of Cancer|February 9, 2005
Antitumour activity of XR5944 in vitro and in vivo in combination with 5-fluorouracil and irinotecan in colon cancer cell linesS M Harris, P Mistry, C Freathy, et al.
Cancer Letters|January 24, 2007
Structural basis for potent inhibition of the Aurora kinases and a T315I multi-drug resistant mutant form of Abl kinase by VX-680G M T Cheetham, P A Charlton, J M C Golec, et al.
The International Journal of Biochemistry|February 1, 1992
Inhibition of aspartic proteinases by synthetic peptides derived from the propart region of human proreninA D Richards, J Kay, B M Dunn, et al.
The Biochemical Journal|April 1, 1987
The rapid purification and partial characterization of human serum angiotensinogenC J Campbell, P A Charlton, C J Grinham, et al.
The Journal of Pediatrics|August 10, 2000
Nutritional rickets in African American breast-fed infantsS R Kreiter, R P Schwartz, H N Kirkman, et al.
Biochemistry|March 31, 1981
Hydrogen-1 nuclear magnetic resonance study of the complexes of two diastereoisomers of folinic acid with dihydrofolate reductaseJ Feeney, B Birdsall, J P Albrand, et al.
Thrombosis and Haemostasis|May 1, 1996
Evaluation of a low molecular weight modulator of human plasminogen activator inhibitor-1 activityP A Charlton, R W Faint, F Bent, et al.
Pageof 2